SoleChem

Atomoxetine

CAS 83015-26-3
EC 617-427-9
Formula C17H21NO
MW 255.35 g/mol
Pharmaceutical Intermediates Pharmaceuticals & Healthcare

Description

Atomoxetine (CAS 83015-26-3, EC 617-427-9, formula C17H21NO) is a selective norepinephrine reuptake inhibitor developed under the research code LY-139603 and commercialised as Strattera. It is also referenced by the synonyms Tomoxetine and Tomoxetina. No E-code applies to this substance.

In pharmaceutical manufacturing, atomoxetine serves primarily as an active pharmaceutical ingredient in ADHD therapies, where it blocks the presynaptic norepinephrine transporter to modulate catecholamine signalling in the prefrontal cortex. It also functions as a reference standard and synthetic intermediate in CNS drug research programmes targeting monoamine reuptake mechanisms.

Atomoxetine is supplied as a pharmaceutical-grade material aligned with relevant pharmacopoeial specifications and subject to REACH registration requirements within the European Economic Area. Procurement teams should confirm purity documentation, GMP compliance status, and controlled-substance classification applicable in the destination country before ordering.

Physical Properties

Boiling Point 389.0±37.0 °C(Predicted)
Density 1.023±0.06 g/cm3(Predicted)

Other Names

Strattera®TomoxetinaTomoxetineTomoxetineHcl(-)-Tomoxetine(r)-tomoxetine(R)-Atomoxetine

Related Products

Need a chemical? Get a quote within 24 hours.

Call Request Quote